You are here

A Global Active Surveillance for Community Acquired Pneumonia

Last updated on August 9, 2018

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Chrzanow, , 32-500 Poland
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Community Acquired Pneumonia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
50+ years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Adult subjects 50 years of age or older

- Subject must reside in the surveillance area

- Subjects who present to a study healthcare facility where the treating physician
clinically suspects CAP

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Any subject who is transferred to a study healthcare facility after already being
hospitalized for 48 hours or more at any other in-patient facility (such as a
community hospital).

- Hospital Acquired pneumonia (ie, develops signs and symptoms of pneumonia after being
hospitalized for 48 hours or more).

NCT00929721
Pfizer
Completed
A Global Active Surveillance for Community Acquired Pneumonia

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.

Similar Trials

Complicated Intra-abdominal Infection, Hosptial Acquired Pneumonia, Ventilator Associated Pneumonia
NCT03329092
All Genders
18+
Years
Multiple Sites
Urinary Tract Infection (cUTI), Intra-abdominal Infection (cIAI) and, Nosocomial Pneumonia (NP)
NCT02364284
All Genders
18+
Years
Multiple Sites
Pneumococcal Pneumonia, Community Acquired Infections, Gram-positive Bacterial Infections
NCT00035269
All Genders
13+
Years
Multiple Sites
Pneumonia
NCT00137007
All Genders
A Global Active Surveillance for Community Acquired Pneumonia
Global Active Surveillance for Community-Acquired Pneumonia (CAP) in Adults 50 Years and Older
This study is an observational surveillance study to identify adults 50 years and older who present to a study healthcare facility with signs and symptoms of Community-Acquired Pneumonia.
Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Community Acquired Pneumonia
  • Procedure: Blood draw
    culture for Streptococcus pneumoniae Frequency-1
    Other Name: Blood stick
  • Procedure: Chest X-ray
    image of the lungs to assess changes consistent with pneumonia Frequency-1
    Other Name: Picture of lungs
  • Procedure: urine specimen
    assay for the presence of Streptococcus pneumoniae Binax and UAD
    Other Name: urine dipstick test
  • Procedure: Nasopharyngeal swab
    culture for Streptococcus pneumoniae Frequency-1
    Other Name: swab from inside the nose and throat
  • Procedure: sputum
    culture for Streptococcus pneumoniae Frequency-1
    Other Name: collection secretions produced during cough
Subjects with Community-Acquired Pneumonia
Subjects with Community-Acquired Pneumonia
Interventions:
  • Procedure: Blood draw
  • Procedure: Chest X-ray
  • Procedure: urine specimen
  • Procedure: Nasopharyngeal swab
  • Procedure: sputum
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
5172
February 2012
January 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Adult subjects 50 years of age or older
  • Subject must reside in the surveillance area
  • Subjects who present to a study healthcare facility where the treating physician clinically suspects CAP

Exclusion Criteria:

  • Any subject who is transferred to a study healthcare facility after already being hospitalized for 48 hours or more at any other in-patient facility (such as a community hospital).
  • Hospital Acquired pneumonia (ie, develops signs and symptoms of pneumonia after being hospitalized for 48 hours or more).
Sexes Eligible for Study: All
50 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Poland
Korea, Republic of
 
NCT00929721
6115A1-4000
No
Not Provided
Not Provided
Pfizer
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
April 2012

ICMJE     Data element required by the

International Committee of Medical Journal Editors
and the
World Health Organization ICTRP

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]



Call Now